A1.01 New diagnostic tools using reagent-less sensors and smart spectroscopy

Optofluidic device as a diagnostic tool using artificial intelligence (AI) algorithms to analyze the optical signature of blood samples. The product will be a highly miniature sensor, incorporating optical guides and fluidics, allowing the analysis of biomarkers without the use of reagents, using the combination of different optical signals, for a more effective diagnosis of various types of cancer that are currently extremely difficult to diagnose early, namely ovarian cancer.Optofluidic device as a diagnostic tool using artificial intelligence (AI) algorithms to analyze the optical signature of blood samples. The product will be a highly miniature sensor, incorporating optical guides and fluidics, allowing the analysis of biomarkers without the use of reagents, using the combination of different optical signals, for a more effective diagnosis of various types of cancer that are currently extremely difficult to diagnose early, namely ovarian cancer.

Date Start

Jan. 2, 2023

Date End

Dec. 31, 2025